Message boards index | Help | Search messages | Sign in


+ UKCAB + Public area + News, events, announcments + WHO launches the 2013 Consolidated ARV Guidelines

WHO launches the 2013 Consolidated ARV Guidelines

Print
Pages: 1

Mark Platt
Member
Posts: 290
WHO launches the 2013 Consolidated ARV Guidelines
Posted on: July 3 2013, 05:00 pm

The WHO launched the 2013 Consolidated ARV Guidelines yesterday afternoon (30 June 2013). The Global Network of People Living with HIV (GNP+), the International HIV/AIDS Alliance (the Alliance) and STOP AIDS NOW(SAN!) issued a joint statement. The joint statement calls on government, multilateral and bilateral agencies, and donors to ensure that communities are meaningfully engaged as countries implement these guidelines. To read the joint statement click here:  http://www.gnpplus.net/images/stories/FINAL_WHO_ARV_Guidelines_Joint_Statement_GNP_IHAA_SAN.pdf and the text is below.
 
Please contact Rhon Reynolds (rreynolds@gnpplus.net) if you have any questions.

Joint Statement by
the Global Network of People Living with HIV, the International HIV/AIDS Alliance and
STOP AIDS NOW!
 
Communities vital to delivering on the promise of new global HIV treatment guidelines
 
 
-         More people living with HIV qualify to start treatment and the scale up of high quality HIV services is crucial to offer safer and more effective treatment
-         New guidelines strongly recommend a range of community-based services that are critical to guarantee the best possible outcomes for people living with HIV and their communities
-         A human rights-based approach is key to the successful roll-out of the new guidelines
-         Strategic investments and supportive political environments are essential for communities to engage in shaping and implementing the new guidelines
 
The Global Network of People Living with HIV (GNP+), the International HIV/AIDS Alliance (the Alliance), and STOP AIDS NOW! (SAN!), today welcomed the World Health Organisation’s (WHO’s) new guidelines on the use of antiretroviral therapy (ART) for the treatment and prevention of HIV and called on governments, multilateral and bilateral agencies, and donors to ensure that communities are meaningfully engaged as countries implement these guidelines.
 
The WHO guidelines were launched at the 7th International AIDS Society conference on HIV Pathogenesis Treatment and Prevention taking place in Kuala Lumpur this week.
 
The new guidelines recommend that people living with HIV can start ART with a CD4 count of 500 cells/mm3 or less compared with a CD4 count of 350 cells/mm3 or less previously (2010 WHO ART Guidelines). Starting treatment earlier has shown to slow clinical progression, reduce the chance of life-threatening conditions such as tuberculosis (TB), and has the added benefit of reducing the risk of HIV transmission. The guidelines also recommend offering treatment regardless of CD4 count (i.e. immediate treatment after HIV diagnosis) to pregnant women, people living with TB or H epatitis B, children under five years old, and people in relationships where one partner is living with HIV and the other is not. To download the full recommendations go to the WHO site:
 
We support the emphasis on offering quality treatment sooner to people living with HIV that meets their differing personal health needs, and delivering treatment in a sustainable manner that increases choice and improves health.
 
The ownership, involvement and action of people living with HIV and their communities has significantly contributed to the increase in access to ART over the past decade. To ensure continued improvements in health for all, the WHO and health ministries must partner with communities to create an enabling political and legal environment for communities to ensure that individual human rights are protected, for instance by integrating and monitoring human rights aspects of the new guidelines to protect the health and rights of people living with HIV and other key populations.
 
The guidelines recognise the constraints of health systems to deliver the optimal standard of care in resource poor settings and gaps remain in treatment coverage. That is why governments and donors must ensure strategic investments that support and scale-up effective community-based interventions – such as peer outreach workers, community-based testing, treatment literacy projects, community advocacy - that improve people’s ability to know their HIV status, and to access quality treatment and care that they need to stay healthy.
 
Last year, GNP+ and the Alliance, in collaboration with WHO, conducted a community consultation to inform the revised guidelines and help countries to make the best strategic decisions on the use of antiretrovirals. Throughout the consultation, community respondents emphasised the critical need for meaningful community engagement at all levels once countries begin adapting and implementing the 2013 guidelines. To download a copy of the Executive Summary of the Community Consultation Report, go to Executive Summary.
 
To support communities to position themselves in discussions on the use of treatment for both health and prevention, GNP+, the Alliance, and SAN! are collaborating with partners to develop a “Community Guide” for use by networks, community-based organisations, and other civil society supporting community action on HIV. The Guide will be launched later on this year at ICAAP and ICASA.
 
 
Kevin Moody, Global Network of People Living With HIV
Anja Teltschik, International HIV/AIDS Alliance
Yvette Fleming, Stop AIDS NOW!
Logged
Silvia Petretti
Steering group
Posts: 286
Re: WHO launches the 2013 Consolidated ARV Guidelines
Reply #1 on: July 4 2013, 12:41 pm

Thanks for posting this Mark.

There are also lots of concerns among women's rights groups because of decision of putting all under 5s with HIV on ARV  treatment.

Please read letter of concern presented at IAC in Kuala Lumpur here:

https://www.dropbox.com/sh/33hfnqmehods4ge/sqm5U4-ykd
Logged

Print
Pages: 1

+ UKCAB + Public area + News, events, announcments + WHO launches the 2013 Consolidated ARV Guidelines